Featuring a slide presentation and related discussion from Professor Arndt Vogel, including the following topics:
- Advances in first-line treatment for patients with advanced hepatocellular carcinoma (HCC) (0:00)
- Outcomes of Phase III clinical trials evaluating single-agent immunotherapy as initial treatment for advanced HCC (4:19)
- Immune checkpoint inhibitors as second-line treatment for recurrent HCC (6:03)
- Combination therapy as initial treatment for advanced HCC (8:05)
- Sequencing therapies for advanced HCC (13:20)
- Future directions in caring for patients with advanced HCC (22:43)
CME information and select publications
Research To Practice | Oncology Videos